July 2020—Oxford Immunotec announced the release of the research use only T-Spot Discovery SARS-CoV-2 test kit.
T-Spot Discovery SARS-CoV-2 builds on the company’s experience with tuberculosis diagnosis and the assessment of immune response to cytomegalovirus in transplant patients. The technology interrogates the immune system’s T cell response and will enable research into the measurement of the strength of that response to SARS-CoV-2. The strength of this response may be linked to protection from reinfection, the company said in a press release.
T-Spot technology uses a standardized sample prepared from peripheral blood, which standardizes cell numbers in the test to normalize for cell number variations between samples and allows the number of responding T cells to be enumerated for a more precise assessment of the T cell response.
Oxford Immunotec, 508-481-4648